Join to View Full Profile
9500 Euclid Ave Ca60Cleveland, OH 44195
Phone+1 216-444-4730
Fax+1 216-636-9286
Dr. Wee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2018 - 2021
- Cleveland Clinic FoundationChief Residency, Internal Medicine, 2017 - 2018
- Cleveland Clinic FoundationResidency, Internal Medicine, 2014 - 2017
- Wayne State University School of MedicineClass of 2014
Certifications & Licensure
- NY State Medical License 2025 - 2027
- SC State Medical License 2025 - 2027
- IL State Medical License 2025 - 2026
- KY State Medical License 2024 - 2026
- NC State Medical License 2025 - 2026
- PA State Medical License 2024 - 2026
- IN State Medical License 2024 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- Minimizing Toxicity From Chemotherapy in Early-Stage Testicular Cancer.Monica Lee, Timothy Gilligan, Christopher E Wee
JCO Oncology Practice. 2025-07-23 - Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab.Moshe C Ornstein, Laeth George, Wei Wei, C Marcela Diaz-Montero, Pat Rayman
Clinical Genitourinary Cancer. 2024-12-01 - 5 citationsPlatinum ineligibility and survival outcomes in patients with advanced urothelial carcinoma receiving first-line treatment.Shilpa Gupta, Alexander Andreev-Drakhlin, Otto Fajardo, Marcella Fassò, Jorge A Garcia
Journal of the National Cancer Institute. 2024-04-05
Press Mentions
- Fracture Risk down with Osteoporosis Drug in Metastatic Prostate CancerJuly 23rd, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: